animals suffer from health problems and need regular health checkups, which is why the animal pharmaceuticals market is growing rapidly. Pharmaceuticals for animals are utilized for treating, diagnosing, and curing veterinary disorders and diseases. In addition to this, the consumption of protein-rich foods, such as meat, eggs, and milk is on a rise all across the globe. Animals that are reared for the purpose of consumption need to be free of any kind of diseases, otherwise, the disease may be transmitted to human beings. This is further resulting in the rising demand for animal pharmaceuticals.
United States Specialty Pharmaceutical Market will be US$ 387 Billion by 2026. Forecast by Application (Oncology, Autoimmune, Immunology, HIV, Multiple Sclerosis, Hematology, AMD, HGH, Others), Company Analysis.
Market Reports on India present the latest report on “OTC Pharmaceuticals Industry in India”, The profile also contains descriptions of the leading players including key financial metrics.
According to #TechSci Research report, Vietnam Pharmaceuticals Market has shown promising growth by 2019 and is expected to continue its growth in upcoming forecast years 2021 to 2026. Gain More Insight: https://bit.ly/3tkYuxJ Get Sample Report: https://bit.ly/33iGUzw Press Release: https://bit.ly/3qhtk8o Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
Halal Pharmaceuticals Market research report provides in depth analysis of the industry along with important statistics and facts. With the help of this information, stakeholders can plan their business strategies.
Ascepion Pharmaceuticals, Inc. - Product Pipeline Review report captures in-depth business analysis and cover major geographies to seize winning business strategies. The study of Ascepion Pharmaceuticals, Inc. - Product Pipeline identifies market share, future trends, opportunities and forecasts.
Lipella Pharmaceuticals, Inc. - Product Pipeline Review Report - 2015 captures in-depth business analysis and cover major geographies to seize winning business strategies. The study of Lipella Pharmaceuticals, Inc Product Pipeline identifies market share, future trends, opportunities and forecasts.
The BRIC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Peregrine Pharmaceuticals, Inc. - Product Pipeline Review - 2014’, provides an overview of the Peregrine Pharmaceuticals, Inc.’s pharmaceutical research and development focus.
Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. For More Details: http://goo.gl/dYK5tE
Pharmaceuticals Pouch Market Report is a comprehensive, professional report provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue and share analysis.
Anti-counterfeit is enforcement of remedial measures that helps in minimizing the counterfeiting activities. The global anti-counterfeit packaging (Pharmaceutical and Cosmetics) market has generated a revenue of $35.7 billion in 2014 and is forecast to grow at a CAGR of 15.7% over the forecast period. Get Free Sample of This Report at: https://goo.gl/uehwHE
This report provides comprehensive information on the current therapeutic developmental pipeline of Peregrine Pharmaceuticals Inc. s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Enquiry @ http://www.researchbeam.com/peregrine-pharmaceuticals-inc-product-pipeline-review-2015-market/enquire-about-report
Global Markets Directs, ‘Agios Pharmaceuticals Inc. - Product Pipeline Review - 2015, provides an overview of the Agios Pharmaceuticals Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Agios Pharmaceuticals Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Enquiry @ http://www.researchbeam.com/agios-pharmaceuticals-inc-product-pipeline-review-2015-market/enquire-about-report
Specialty pharmaceuticals are regarded to be a drug molecule that helps in the treatment of particular genetic conditions that have no therapeutic action on the market. For More Information Call Us : +1 678-302-0700 Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=specialty-pharmaceutical-market-p.php
This report provides comprehensive information on the current therapeutic developmental pipeline of GeneScience Pharmaceuticals Co. Ltd. s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Enquiry @ http://www.researchbeam.com/genescience-pharmaceuticals-co-ltd-product-pipeline-review-2015-market/enquire-about-report
The report provides year on year opportunity spends value within the Pharmaceuticals sector; split across BPO Services, Cloud Services, Enterprise Communications Services, IT Hardware, IT Services, and Software categories and further at segment levels for the period 2016 to 2019.
This report provides comprehensive information on the current therapeutic developmental pipeline of Aslan Pharmaceuticals Pte. Ltd. s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Enquiry @ http://www.researchbeam.com/aslan-pharmaceuticals-pte-ltd-product-pipeline-review-2015-market/enquire-about-report
Halal pharmaceuticals are those medicines that stringently adhere to Shariah law. More specifically, halal pharmaceuticals refer to medicines that should not contain any parts of animals (dogs, pigs and ones particularly with pointed teeth), insects (bees), alcohol and other substances prohibited as ‘haram’ under the Shariah law.
Big Market Research has announced a new report “Global Anti-counterfeit Pharmaceuticals Packaging Industry - Size, Share, Trends, Forecast, Growth, Opportunities 2021” Get Complete Report @ http://www.bigmarketresearch.com/global-anti-counterfeit-pharmaceuticals-packaging-industry-deep-research-report-market The Global Anti-counterfeit Pharmaceuticals Packaging Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Anti-counterfeit Pharmaceuticals Packaging industry. Enquire about this report @ http://www.bigmarketresearch.com/report-enquiry/366544
This report provides comprehensive information on the current therapeutic developmental pipeline of Orphagen Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. See Full Report @ bit.ly/143JWUl
“Ajinomoto Pharmaceuticals Co., Ltd. - Product Pipeline Review – 2014”, provides an overview of the Ajinomoto Pharmaceuticals Co., Ltd.s pharmaceutical research and development focus. For more details : http://goo.gl/ZX9qkw
Brazil's traditional commitment to healthcare improvement and growing middle-class population present significant revenue-generating opportunities for multinationals in the country. The Brazilian pharmaceutical market is now an integral part of all large pharmaceutical companies' strategic outlook.
Pharmaceutical excipients market is classified as organic and inorganic based on the type of pharmaceutical excipient products commercially available. Rise in healthcare expenditures, demand for new drug delivery systems along with need for enhanced medications are generating impetuous on pharmaceutical excipients market.
The Global And China Pet Pharmaceuticals Industry 2017 Market Research Report is a professional and in-depth study on the current state of the Pet Pharmaceuticals industry.
A new trending note at JSB market research on “Dragonite International Limited (329) - Pharmaceuticals & Healthcare - Deals and Alliances Profile” http://www.jsbmarketresearch.com/healthcare-medical/r-Dragonite-International-Limited-329-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-246829 The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
Turkey Pharmaceuticals and Healthcare Report Q3 2014 @ http://www.lifescienceindustryresearch.com/turkey-pharmaceuticals-and-healthcare-report-q3-2014.html BMI View: Data released by the Turkish drugmakers association for 2013 sales corresponds with our own forecasts. We have also modified our pharmaceutical sales forecast for 2014 and beyond to reflect the volatile exchange rate situation. We now see Turkey’s lustre as an emerging pharmaceutical market regressing over the medium term. We believe that the business environment will continue to impede the industry and see very little scope for the central government to enact business-friendly reform in the sector. In sum, we believe 2014 will be another disappointing and challenging year for the industry.
Big Market Research, TetraLogic Pharmaceuticals Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014. Global Markets Direct’s, ‘TetraLogic Pharmaceuticals - Product Pipeline Review - 2014’, provides an overview of the TetraLogic Pharmaceuticals’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of TetraLogic Pharmaceuticals’s, complete with comparative analysis at various stages, therapeutics assessment by drug target.
Equine Pharmaceuticals and Supplements Market: Global Industry Analysis, Trends, Market Size, and, Forecasts up to 2023 The report on Equine Pharmaceuticals and Supplements Market by product type (pharmaceuticals and supplements), by distribution channels (veterinary hospitals, drugstores, and some others) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Equine Pharmaceuticals and Supplements Market is projected to grow at a CAGR between 2.0% to 2.5% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
Mylan Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Mylan Pharmaceuticals, Inc. since January 2007. Browse full report @ http://bit.ly/1GDFGvh
This Report provided by 24 Market Reports is about, the Pharmaceuticals Packaging in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Big Market Research “Emerging Pharmaceuticals Markets” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/emerging-pharmaceuticals-in-china-market China's demand for Emerging Pharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades.
2016 Global Anti-counterfeit Pharmaceuticals and Cosmetics Packaging Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Anti-counterfeit Pharmaceuticals and Cosmetics Packaging industry.
"GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014"report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.
Big Market Research, Tetraphase Pharmaceuticals Inc. Product Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014.Global Markets Direct’s, ‘Tetraphase Pharmaceuticals Inc. - Product Pipeline Review - 2014’, provides an overview of the Tetraphase Pharmaceuticals Inc.’s pharmaceutical research and development focus.
Big Market Research, Partnerships, Licensing, Investments and M&A Deals and Trends for January 2015 in Pharmaceuticals Market Size, Share, Strategies, Trends, Application, Forecast, Industry Analysis, Research, Report. This report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in January 2015. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies.
Big Market Research : World Anti-counterfeit Pharmaceuticals and Cosmetics Packaging Market - Size, Share, Trends, Demand, Report, Opportunities and Forecast 2021 To Get More Details @ http://www.bigmarketresearch.com/anti-counterfeit-pharmaceuticals-and-cosmetics-packaging-market Anti-counterfeit is enforcement of remedial measures that helps in minimizing the counterfeiting activities. The global anti-counterfeit packaging (Pharmaceutical and Cosmetics) market has generated a revenue of $35.7 billion in 2014 and is forecast to grow at a CAGR of 15.7% over the forecast period.
Get a sample brochure @ http://tinyurl.com/ha35dgb Anti-counterfeit is enforcement of remedial measures that helps in minimizing the counterfeiting activities. The global anti-counterfeit packaging (Pharmaceutical and Cosmetics) market has generated a revenue of $35.7 billion in 2014 and is forecast to grow at a CAGR of 15.7% over the forecast period. Pharmaceutical, cosmetics and personal care products are the first line of target for counterfeiters. The fact behind the rigorous counterfeiting activities is the presence of high volume low value manufacturing nature of the market.
“Partnerships, Licensing, Investments and M&A Deals and Trends for 2015 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in 2015. The report portrays detailed comparative data on the number of deals and their value in the last five years, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
Big Market Research, Axikin Pharmaceuticals Inc. Product Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014.Axikin Pharmaceuticals, Inc. - Product Pipeline Review - 2014’, provides an overview of the Axikin Pharmaceuticals, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Axikin Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Big Market Research, Enceladus Pharmaceuticals BV Product Market Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014.‘Enceladus Pharmaceuticals BV - Product Pipeline Review - 2014’, provides an overview of the Enceladus Pharmaceuticals BV’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Enceladus Pharmaceuticals BV’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Grifols Therapeutics, Inc. (Grifols) formerly Talecris Biotherapeutics Inc, is a US-based publicly held pharmaceutical company. It engages in development, production, marketing and distribution of therapies for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), primary immune deficiencies (PI), alpha-1 antitrypsin deficiency, bleeding disorders, infectious diseases and severe trauma. Browse Full Report @ http://bit.ly/1tgUUMm
... Prevention is better than cure First address causes of disease Refocus health care towards holistic treatment Review pharmaceutical legislation ...
Infinium Global Research has added a new report on Global Equine Pharmaceuticals and Supplements Market. The report predicts the market size of Equine Pharmaceuticals and Supplements is expected to reach XX billion by 2023.
The global animal pharmaceuticals market was valued at $12,614.3 million in 2015, and it is expected to grow at a CAGR of 7.7% during 2016 - 2022. The growth of the global market is largely driven by increasing consumption of meat and milk, and increasing zoonotic and food borne diseases. Due to growing health concern of related animals and their increasing number, the healthcare expenses in farms are surging globally.
Some key players in the Saudi Arabia pharmaceutical market covered in this report are SPIMACO, Tabuk Pharmaceuticals Manufacturing Co., Juphar, Jamjoom Pharma, GlaxoSmithKline plc. Pfizer Inc., Novartis AG and Sanofi.
The major players in the global pharmaceutical contract development and manufacturing market are Recipharm AB, Pfizer Inc., Boehringer Ingelheim International GmbH., Aenova Group, Famar, Jubilant Life Sciences Limited,, Catalent Pharma Solutions, Chemicals Limited, Dishman Pharmaceuticals ,
According to the latest report by Renub Research, The Global Specialty Pharmaceuticals market is expected to be USD 568 Billion by 2026. Market Size by Countries (US, UK, France, Germany, Italy, Spain, Japan, South Korea). Contact a Sample Report at info@renub.com